To hear about similar clinical trials, please enter your email below
Trial Title:
Application of Cognitive Training Based on the Remind Strategy in Glioma Patients With Cognitive Impairment
NCT ID:
NCT06327048
Condition:
Glioma
Conditions: Official terms:
Glioma
Cognitive Dysfunction
Conditions: Keywords:
cognitive training
cognitive impairment
Quality of Life
Study type:
Interventional
Study phase:
N/A
Overall status:
Recruiting
Study design:
Allocation:
Non-Randomized
Intervention model:
Parallel Assignment
Intervention model description:
Non-randomized intervention study
Primary purpose:
Other
Masking:
Single (Outcomes Assessor)
Masking description:
Blind the evaluator
Intervention:
Intervention type:
Other
Intervention name:
Individual cognitive rehabilitation training based on Remind strategy was given
Description:
This training educates and learns patients from the aspects of assessment of cognitive
function and strategic compensation for the impact of cognitive impairment on patients,
and then conducts attention, memory and executive function training and attention
retraining based on patients' cognitive function to improve patients' cognitive function
Arm group label:
Intervention group
Summary:
The purpose of this study is to form an interdisciplinary team to dynamically evaluate
patient cognitive outcomes and develop an individualized cognitive training program for
Chinese brain tumor patients
Detailed description:
Adult patients diagnosed with glioma who meet the inclusion criteria will be enrolled in
this study. Patients admitted to Neurosurgery Ward 1 and Ward 2 will be assigned to the
intervention group, while those admitted to Neurosurgery Ward 3 and Ward 4 will serve as
the control group. The intervention group will receive cognitive rehabilitation training
based on the Remind strategy in addition to standard rehabilitation care, whereas the
control group will receive only standard rehabilitation care. Assessment of patients'
cognitive function, quality of life, psychological status, and the effectiveness of
cognitive training intervention will be conducted on the first day of admission, one day
before discharge, and at the end of the intervention period.
Criteria for eligibility:
Criteria:
Inclusion Criteria:
1. Conforming to the diagnostic criteria outlined in the "Chinese Clinical Guidelines
for Diagnosis and Treatment of Central Nervous System Gliomas (2015)" ;
2. Patients diagnosed with brain gliomas through histopathological and/or cytological
examination;
3. MoCA (Montreal Cognitive Assessment) score ≤ 26;
4. Karnofsky Performance Status (KPS) score ≥ 60, with no history of past illnesses;
5. Age ≥ 18 years;
6. Clear consciousness;
7. Willingness to participate and signed informed consent form.
Exclusion Criteria:
1. Diagnosed with neurological or psychiatric disorders within the past two years;
2. Impaired consciousness;
3. Accompanied by severe complications such as infections;
4. Nursing Delirium Screening Checklist (Nu-DESC) score ≥ 2;
5. Patients with changes in condition or requiring repeat surgery;
6. Patients with multiple intracranial tumors;
7. Inability to effectively complete the questionnaire or withdrawal during the study.
Gender:
All
Minimum age:
18 Years
Maximum age:
70 Years
Healthy volunteers:
No
Locations:
Facility:
Name:
Yuanyuanma
Address:
City:
Lanzhou
Country:
China
Status:
Recruiting
Contact:
Last name:
yuanyuan ma, Bachelor
Phone:
18809406184
Email:
1657107645@qq.com
Start date:
March 6, 2024
Completion date:
December 1, 2024
Lead sponsor:
Agency:
YuanYuan Ma
Agency class:
Other
Source:
LanZhou University
Record processing date:
ClinicalTrials.gov processed this data on November 12, 2024
Source: ClinicalTrials.gov page:
https://clinicaltrials.gov/ct2/show/NCT06327048
